Profile
Anne-Marie Law served as the Chief Human Resource Officer & Executive VP at Alexion Pharmaceuticals, Inc. from 2017 to 2019.
Prior to that, she was the Senior Vice President-Global Human Resources at VeriSign, Inc. and the Executive Vice President & Head-Human Resources at Baxalta, Inc. In 2016, she served as the Chief Human Resources Officer & EVP at Hyatt Hotels Corp.
She also worked as the Senior Vice President-Human Resources at McKesson Specialty Care Solutions from 2009 to 2010.
Ms. Law received her undergraduate degree from the University of Leicester and another undergraduate degree from the National College of Ireland.
Former positions of Anne-Marie Law
| Companies | Position | End |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Human Resources Officer | 12/02/2019 |
| HYATT HOTELS CORPORATION | Human Resources Officer | 05/09/2017 |
| McKesson Specialty Care Solutions | Human Resources Officer | 01/12/2010 |
| BAXALTA INC | Human Resources Officer | - |
| VERISIGN. INC. | Human Resources Officer | - |
Training of Anne-Marie Law
| University of Leicester | Undergraduate Degree |
| National College of Ireland | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| VERISIGN. INC. | Technology Services |
| HYATT HOTELS CORPORATION | Consumer Services |
| Private companies | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
| McKesson Specialty Care Solutions |
- Stock Market
- Insiders
- Anne-Marie Law
